Skip to main content
Mikhail Roshal, MD, Pathology, New York, NY

Mikhail Roshal MD

Hematopathology, Anatomic Pathology, Clinical Pathology


Assistant Professor, Pathology & Laboratory Medicine, Weill Cornell Medical College

Join to view full profile
  • 1275 York AveNew York, NY 10065

  • Phone+1 212-639-2000

Dr. Roshal is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematopathology, 2009 - 2010
  • University of Washington
    University of WashingtonResidency, Pathology-Anatomic and Clinical, 2005 - 2008
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 2005

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2021 - 2027
  • NY State Medical License
    NY State Medical License 2010 - 2027
  • WA State Medical License
    WA State Medical License 2007 - 2010
  • Pathology - Clinical
    American Board of Pathology Pathology - Clinical
  • Hematopathology
    American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Journal Articles

  • Acquired Resistance to IDH Inhibition Through Trans or Cis Dimer-Interface Mutations  
    Martin S Tallman, Eytan M Stein, Alan H Shih, Maria E Arcila, Andrew M Intlekofer, Craig B Thompson, Mikhail Roshal, Nature

Abstracts/Posters

  • Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute Leukemia
    Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
    Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a Spike-in Clonal Sequence
    Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Circulating Lymphoma Cells in Mycosis Fungoides/Sezary Syndrome Show Heterogeneity of the Cell-of-Origin and Variable PD-1 Expression By Flow Cytometric Analysis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Understanding the Origins of Hodgkin Lymphoma Cells Could Lead to Better Diagnostics
    Understanding the Origins of Hodgkin Lymphoma Cells Could Lead to Better DiagnosticsApril 25th, 2026
  • Understanding Hodgkin Lymphoma Cell Origins Could Yield Better Diagnostics
    Understanding Hodgkin Lymphoma Cell Origins Could Yield Better DiagnosticsApril 29th, 2026
  • Understanding the Origins of Hodgkin Lymphoma Cells Could Lead to Better Diagnostics
    Understanding the Origins of Hodgkin Lymphoma Cells Could Lead to Better DiagnosticsApril 29th, 2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: